Taby Diagnostics and Safety Hug are two innovative projects that have recently been Awarded by FIPSE (Fundación par la Innovación y la Prospectiva en Salud en España). The grant will give the projects the financial resources to cover those expensas associated to the evaluation of the market opportunity.
Taby Diagnostics is developing an in vitro assay to early diagnose liver cancer in cirrhotic patients. Thanks to this test we will duplicate the amount of patients that can be cured. The principal investigator of this project, Dr. Juan Francisco Delgado, has developed a technology that Allows him to increase the immunogenicity of tumor associated antígenos, therefore increasing the sensitivity to detect serum antibodies in patients at risk to develop liver cancer. Dr. Juan Francisco Delgado is Collaborating with Dra. Merced Vergara, co-investigator of the project, and her team, in a prospective study to further validate the test. Thanks to the FIPSE grant we will be able to perform a business plan, including the financial and regulatory needs to bring this test to the market, along with a roadmap and a fundraising strategy.
Safety Hug es un smart harness que pretendes reducir el 50% de la contención en los agitados pacientes mediante la colección de críticas de fecha. El inventor es Javier Perez Acebo, en emergency nurse from Prác Taulí, que es co-developing el producto por Eurecat Technological Center y pretendes para el mercado en 2 years. Thanks to the FIPSE grant, we will be able to better understand how different hospitales en España adaptada contención, y el potencial mercado de producto.
Deje un comentario